Complementary Alternative Cardiovascular Medicine
Complementary Alternative Cardiovascular Medicine
Complementary Alternative Cardiovascular Medicine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Chapter 3 / Botanical <strong>Medicine</strong> and CVD 47<br />
55. Urizar NL, Liverman AB, Dodds DT, et al. A natural product that lowers cholesterol<br />
as an antagonist ligand for the FXR. Science 2002;296:1703–1706.<br />
56. Nityanand S, Kapoor NK. Hypocholesterolemic effect of Commiphora mukul resin<br />
(Guggal). Indian J Exp Biol 1971;9:367–377.<br />
57. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid—a new<br />
hypolipidemic agent. J Assoc Phys India 1989;37:323–338.<br />
58. Malhotra SC, Ahuja MMS, Sundarum KR. Long-term clinical studies on the<br />
hypolipidemic effect of Commiphora mukul (guggul) and clofibrate. Ind J Med<br />
1977;65:390–395.<br />
59. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of<br />
Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia.<br />
Cardiovasc Drug Ther 1994;8:659–664.<br />
60. McGuffin M, Hobbs C, Upton R, Goldberg A. American Herbal Products<br />
Association’s Botanical Safety Handbook. CRC, Boca Raton, FL, 1997.<br />
61. Dalvi SS, Nayak VK, Pohujani SM, Desai NK, Kshirsagar NA, Gupta KC. Effect<br />
of gugulipid on bioavailability of diltiazem and propanolol. J Assoc Phys Ind<br />
1994;42:454–455.<br />
62. Muller A, Linke W, Klaus W. Crataegus extract blocks potassium currents in guniea<br />
pig ventricular cardiac myocytes. Planta Med 1999;65:335–339.<br />
63. Schwinger RH, Pietsch M, Frank K, et al. Crataegus special extract WS 1442 increases<br />
force of contraction in human myocardium cAMP-independently. J<br />
Cardiovasc Pharmacol 2000;35:700–707.<br />
64. Lacaille-Dubois, Franck U, Wagner H. Search for potential angiotensin converting<br />
enzyme (ACE)-inhibitors from plants. Life Sci 2000;67:121–131.<br />
65. Tauchert M. Efficacy and safety of crataegus extract WS 1442 in comparison with<br />
placebo in patients with chronic stable New York Heart Association class-III heart<br />
failure. Am Heart J 2002;143:910–915.<br />
66. Hanack T, Bruckel MH. The treatment of mild stable forms of angina pectoris using<br />
Crataegutt Novo: a double-blind study using placebo as control. Therapiewoche<br />
1983;33:4331–4333.<br />
67. Tauchert M, Ploch M, Hubner WD. Efficacy of hawthorn extract LI 132 in comparison<br />
with captopril: multicentre double-blind study on 132 patients with cardiac<br />
insufficiency of NYHA Grade II. Munch Med Wschr 1994;136:27–33.<br />
68. Weikl A, Assmus KD, Neukum-Schmidt A, et al. Crataegus Special Extract WS<br />
1442. Assessment of objective effectiveness in patients with heart failure (NYHA<br />
II). Fortschr Med 1996;1142:291–296.<br />
69. Rietbrock N, Hamel M, Hempel B, Mitrovic V, Schmidt T, Wolf GK. Actions of<br />
standardized extracts of Crataegus berries on exercise tolerance and quality of life<br />
in patients with congestive heart failure. Arzneimittelforschung 2001;51:793–798.<br />
70. Stitcher O, Meier B. Hawthorn (Crataegus): Biological activity and new strategies<br />
for quality control. In: Lawson LK, Bauer R, eds. Phytomedicines of Europe: Chemistry<br />
and Biological Activity. American Chemical Society, Washington, DC, 1998,<br />
pp. 241–262.<br />
71. Kim SH, Kang KW, Kim KW, Kim ND. Procyanidins in crataegus extract evoke<br />
endothelium-dependent vasorelaxation in rat aorta. Herz 1999;24:465–474.<br />
72. Leuchtgens H. Crataegus special extract WS 1442 in cardiac insufficiency NYHA<br />
II. Fortschr Med 1993;111:20–21.<br />
73. Zhang Z, Ho WK, Huang Y, James AE, Lam LW, Chen ZY. Hawthorn fruit is<br />
hypolipidemic in rabbits fed a high cholesterol diet. J Nutr 2002;132:5–10.
Change language